April 10, 2013 at 19:04 PM EDT
Biotechs, Research Stocks Score Notable New Highs
Utilities and retailers continued to represent a big chunk of new highs, but the most interesting chart action Wednesday was in medical stocks. The biotech industry, which has been rising in IBD's rankings, showed off with strong moves by Regeneron (REGN) and Gilead Sciences (GILD). Regeneron vaulted 10.05, or 5%, to 201.13 in above-average volume. The stock had already become extended from a 178.09 cup-with-handle buy point. Gilead's gain was
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here